Contact this trialFirst, we need to learn more about you.
Chemotherapy
Immunotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Edmonton, Alberta
This trial is testing whether Nivolumab, or a combination of Nivolumab and Ipilimumab, or Nivolumab and Platinum-Doublet Chemotherapy can help people with advanced lung cancer live longer without their disease getting worse, or improve overall survival.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.